<?xml version="1.0" encoding="UTF-8"?>
<p>The essential oil of the X6M6 and X6M9 genotypes in addition to β-myrcene, also showed a high abundance of citral (neral + geranial) as their major composition. The X10M37 genotype, however, disclosed citral and caryophyllene oxide as its major components 
 <xref ref-type="fig" rid="molecules-26-02332-f001">Figure 1</xref>. The chemotype citral in 
 <italic>L. alba</italic> is very well established, and in general, its abundance is reported above 65.00% [
 <xref rid="B1-molecules-26-02332" ref-type="bibr">1</xref>,
 <xref rid="B49-molecules-26-02332" ref-type="bibr">49</xref>]. Studies regarding the chemical composition of myrcene-citral chemotype, on the other hand, have shown an abundance of these compounds similar to our results, ranging 13.00–15.00% of myrcene and 37–53% of citral [
 <xref rid="B33-molecules-26-02332" ref-type="bibr">33</xref>,
 <xref rid="B34-molecules-26-02332" ref-type="bibr">34</xref>]. Citral is an open chain monoterpenoid formed by the neral and geranial stereoisomers found in several medicinal plants and widely used as additives in foods, beverages, and cosmetics, due its intense lemon aroma and flavor [
 <xref rid="B50-molecules-26-02332" ref-type="bibr">50</xref>]. A plethora of pharmacological properties have already been reported to citral, such as antibacterial [
 <xref rid="B51-molecules-26-02332" ref-type="bibr">51</xref>], antifungal [
 <xref rid="B52-molecules-26-02332" ref-type="bibr">52</xref>], insecticide [
 <xref rid="B53-molecules-26-02332" ref-type="bibr">53</xref>], antioxidant [
 <xref rid="B16-molecules-26-02332" ref-type="bibr">16</xref>], anticancer [
 <xref rid="B54-molecules-26-02332" ref-type="bibr">54</xref>], anti-inflammatory [
 <xref rid="B55-molecules-26-02332" ref-type="bibr">55</xref>], and anti-nociceptive [
 <xref rid="B56-molecules-26-02332" ref-type="bibr">56</xref>] activities.
</p>
